We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Sangamo Therapeutics shares dive after poor early-stage trial data
Entertainment Entertainment Headlines News
REUTERS: Sangamo Therapeutics Inc's shares sank 27 percent on Thursday after its gene-editing drug failed to show promise in an early-stage trial ...